期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
A PKS gene, pks-1, is involved in chaetoglobosin biosynthesis, pigmentation and sporulation in Chaetomium globosum 被引量:7
1
作者 HU Yang HAO XiaoRan LOU Jing ZHANG Ping PAN Jiao ZHU XuDong 《Science China(Life Sciences)》 SCIE CAS 2012年第12期1100-1108,共9页
Chaetomium globosum is one of the most common fungi in nature. It is best known for producing chaetoglobosins; however, the molecular basis of chaetoglobosin biosynthesis is poorly understood in this fungus. In this s... Chaetomium globosum is one of the most common fungi in nature. It is best known for producing chaetoglobosins; however, the molecular basis of chaetoglobosin biosynthesis is poorly understood in this fungus. In this study, we utilized RNA inter- ference (RNAi) to characterize a polyketide synthase gene, pks-1, in C. globosum that is involved in the production of chaeto- globosin A. When pks-1 was knocked down by RNAi, the production of chaetoglobosin A dramatically decreased. Knock-down mutants also displayed a pigment-deficient phenotype. These results suggest that the two polyketides, melanin and chaetoglobosin, are likely to share common biosynthetic steps. Most importantly, we found that pks-I also plays a critical role in sporulation. The silenced mutants ofpks-1 lost the ability to produce spores. We propose that polyketides may modulate cellular development via an unidentified action. We also suggest that C. globosum pks-1 is unique because of its triple role in melanin formation, chaetoglobosin biosynthesis and sporulation. This work may shed light on chaetoglobosin biosynthesis and indicates a relationship between secondary metabolism and fungal morphogenesis. 展开更多
关键词 polyketide synthase pkS) MELANIN chaetoglobosin A Chaetomium globosum
原文传递
同期胰肾联合移植12例报告——德国埃森大学的经验
2
作者 郑亚新 李俊 +2 位作者 Paul A Friling A Broelsch CE 《中华器官移植杂志》 CAS CSCD 北大核心 2005年第6期329-331,共3页
目的总结同期胰肾联合移植(SPK)术的治疗效果和经验.方法自2002年1月至2003年9月,以SPK术治疗胰岛素依赖型糖尿病(IDDM)合并终末期肾病(ESRD)患者12例.每例受者接受来自同一供者的胰腺和肾脏,移植肾以经典方法植入左侧盆腔,胰腺植于右下... 目的总结同期胰肾联合移植(SPK)术的治疗效果和经验.方法自2002年1月至2003年9月,以SPK术治疗胰岛素依赖型糖尿病(IDDM)合并终末期肾病(ESRD)患者12例.每例受者接受来自同一供者的胰腺和肾脏,移植肾以经典方法植入左侧盆腔,胰腺植于右下腹.1例移植胰腺静脉与受者门静脉系统吻合,11例与体静脉系统吻合.胰腺外分泌引流方法为:3例移植物十二指肠段与受者十二指肠吻合,9例与空肠上段吻合.术前应用甲泼尼龙及抗胸腺细胞球蛋白作为免疫诱导,术后以他克莫司、霉酚酸酯和泼尼松三联抗排斥药物维持.结果术后平均随访时间23个月,受者、移植胰腺和移植肾的存活率分别为100%、91.7%和91.7%.1例再次行SPK术的受者,术后出现了超急性排斥反应,且未能逆转,于术后13 d切除移植物;其余11例首次行SPK术的受者中,3例(28.3%)出现急性排斥,均获成功纠治.2例受者术后移植肾功能延迟恢复,行过渡性透析.11例首次行SPK术的移植胰腺术后立即发挥了功能,分别于术后1~5 d内停用胰岛素.结论同期胰肾联合移植是胰岛素依赖型糖尿病合并终末期肾病患者的一种安全而有效的治疗方法. 展开更多
关键词 胰肾联合移植 同期 胰岛素依赖型糖尿病 终末期肾病(ESRD) 移植肾功能延迟恢复 抗胸腺细胞球蛋白 2002年1月 超急性排斥反应 大学 德国 移植胰腺 十二指肠吻合 2003年 门静脉系统 胰腺外分泌 抗排斥药物 pk术 治疗效果
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部